Cytokinetics Inc. (CYTK) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CYTK. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|
| BlackRock | 20,094,362 | $1.7B | INCREASED |
| State Street | 6,494,233 | $553M | INCREASED |
| Principal Financial Group | 1,311,664 | $112M | INCREASED |
| Pictet Asset Management Holding | 1,160,463 | $99M | INCREASED |
| BNY Mellon | 1,150,697 | $98M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|
| Andrew Callos (EVP, Chief Commercial Officer) | EXERCISE | 14,000 | $326K | 2026-07-30 |
| Andrew Callos (EVP, Chief Commercial Officer) | SELL | 14,000 | $1M | 2026-07-30 |
| Robert I Blum (President & CEO) | EXERCISE | 7,500 | $80K | 2026-07-27 |
| Robert I Blum (President & CEO) | SELL | 7,500 | $607K | 2026-07-27 |
| Fady Ibraham Malik (EVP Research & Development) | EXERCISE | 3,500 | $27K | 2026-07-21 |
Recent Congressional Trades
| Member | Type | Amount | Date |
|---|
| Gilbert Cisneros (Democrat) | PURCHASE | $1,001 - $15,000 | 2026-06-30 |
Full institutional holdings, insider history, and congressional trades for Cytokinetics Inc. on SentiSense.